STOCK TITAN
  1. Home
  2. Sec-filings
  3. BWAY
  4. [Form 4] Brainsway Ltd. Insider Trading Activity

Brainsway (BWAY) CTO sells 5,000 shares after exercising options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Brainsway Ltd. Chief Technology Officer Moiseyev Gilad reported multiple equity transactions. On May 25, 2026, he exercised stock options for 7,500 Ordinary Shares at an exercise price of NIS 11.17 per share, and the company retained 1,902 shares at NIS 44.04 per share to cover the option exercise.

On June 15, 2026, he sold 5,000 Ordinary Shares in an open-market transaction at a sale price of NIS 42.0397 per share, leaving him with 53,098 Ordinary Shares held directly. Footnotes indicate remaining stock options to purchase 13,125 Ordinary Shares vesting in equal quarterly installments until March 5, 2028, alongside additional unvested RSUs that settle in Ordinary Shares over future dates.

Positive

  • None.

Negative

  • None.
Insider Moiseyev Gilad
Role Chief Technology Officer
Sold 5,000 shs ($0.00)
Type Security Shares Price Value
Sale Ordinary Shares 5,000 $0.00 --
Exercise Stock Options (right to buy) 7,500 $0.00 --
Exercise Ordinary Shares 7,500 $0.00 --
Tax Withholding Ordinary Shares 1,902 $0.00 --
Holdings After Transaction: Ordinary Shares — 53,098 shares (Direct, null); Stock Options (right to buy) — 22,500 shares (Direct, null)
Footnotes (1)
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price is NIS 11.17 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. The sale price was NIS 42.0397 per share. Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.
Shares sold 5,000 Ordinary Shares Open-market sale on June 15, 2026
Sale price NIS 42.0397 per share Price for 5,000-share sale on June 15, 2026
Options exercised 7,500 Ordinary Shares Option exercise on May 25, 2026
Exercise price NIS 11.17 per share Exercise price for 7,500 options
Shares retained by company 1,902 Ordinary Shares Retained at NIS 44.04 per share for exercise payment
Post-transaction holdings 53,098 Ordinary Shares Direct ownership after June 15, 2026 sale
Remaining options 13,125 Ordinary Shares Options vesting quarterly until March 5, 2028
American Depositary Shares financial
"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
restricted stock units ("RSUs") financial
"This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
tax liability financial
"Payment of exercise price or tax liability by delivering securities"
Stock options financial
"Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting..."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moiseyev Gilad
(Last)(First)(Middle)
16 HARTUM STREET, RAD TOWER, 14TH FLOOR
HAR HAHOTZVIM
(Street)
JERUSALEM9777516
(City)(State)(Zip)
ISRAEL
(Country)		2. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/25/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares(1)05/25/2026M7,500A(2)60,000(3)D
Ordinary Shares(1)05/25/2026F1,902D(4)58,098(3)D
Ordinary Shares(1)06/15/2026S5,000D(5)53,098(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (right to buy)(2)05/25/2026M7,500 (6)03/05/2034Ordinary Shares(1)7,500$022,500D
Explanation of Responses:
1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. The exercise price is NIS 11.17 per share.
3. This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
4. These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.
5. The sale price was NIS 42.0397 per share.
6. Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.
/s/ Gilad Moiseyev06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Brainsway (BWAY) CTO Moiseyev Gilad report?

Brainsway CTO Moiseyev Gilad reported exercising options for 7,500 Ordinary Shares and selling 5,000 shares. The filing also shows shares retained by the company for tax and exercise costs and remaining options and RSUs that vest in future periods.

How many Brainsway (BWAY) shares did the CTO sell and at what price?

The CTO sold 5,000 Brainsway Ordinary Shares in an open-market transaction at a sale price of NIS 42.0397 per share. This transaction occurred on June 15, 2026, and followed a prior option exercise that increased his shareholdings.

What stock options did the Brainsway (BWAY) CTO exercise in this Form 4?

On May 25, 2026, the CTO exercised stock options for 7,500 Ordinary Shares at an exercise price of NIS 11.17 per share. These options were part of a grant dated March 5, 2024, with remaining options vesting quarterly until March 5, 2028.

How many Brainsway (BWAY) shares does the CTO hold after these transactions?

After the reported transactions, the CTO directly holds 53,098 Ordinary Shares. Footnotes state this figure includes both Ordinary Shares and unvested RSUs, which may convert into additional Ordinary Shares as they vest over several future vesting dates.

Were any Brainsway (BWAY) shares used for tax or exercise payments in this filing?

Yes. The filing shows 1,902 Ordinary Shares were retained by Brainsway at NIS 44.04 per share. According to the footnotes, these shares were retained by the company as payment of the exercise price for employee stock options exercised by the CTO.

What unexercised Brainsway (BWAY) options and RSUs remain for the CTO?

Footnotes state the CTO has remaining options to purchase 13,125 Ordinary Shares, vesting quarterly until March 5, 2028. He also holds several tranches of unvested RSUs, each representing a contingent right to receive one Ordinary Share over future quarterly vesting schedules.